Form 8-K - Current report:
SEC Accession No. 0000950170-25-053238
Filing Date
2025-04-11
Accepted
2025-04-11 16:01:56
Documents
11
Period of Report
2025-04-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K acet-20250407.htm   iXBRL 8-K 44007
  Complete submission text file 0000950170-25-053238.txt   158354

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20250407.xsd EX-101.SCH 25038
14 EXTRACTED XBRL INSTANCE DOCUMENT acet-20250407_htm.xml XML 4753
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 25831510
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)